Skip to main content
Log in

Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Circulating endothelial progenitor cells (EPCs) have a critical role in endothelial maintenance and repair. Apolipoprotein A-I mimetic peptide D-4F has been shown to posses anti-atherogenic properties via sequestration of oxidized phospholipids, induction of remodeling of high density lipoprotein and promotion of cholesterol efflux from macrophage-derived foam cells. In this study, we test the effects of D-4F on EPC biology. EPCs were isolated from the peripheral venous blood of healthy male volunteers and characterized by 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine-labeled acetylated LDL uptake and ulex europaeus agglutinin binding and flow cytometry. Cell proliferation, migration, adhesion, nitric oxide production and endothelial nitric oxide synthase (eNOS) expression in the absence and presence of D-4F or simvastatin (as a positive control), were assayed. We demonstrated that D-4F significantly enhanced EPC proliferation, migration and adhesion in a dose-dependent manner compared with vehicle. However, all of the favorable effects of D-4F on EPCs were dramatically attenuated by preincubation with NOS inhibitor L-NAME. Further, D-4F also increased nitric oxide production in culture supernatant and the levels of eNOS expression and phosphorylation. The stimulatory effects of D-4F (10 μg/ml) on EPC biology were comparable to 0.5 μM simvastatin. These results suggest that eNOS/NO pathway mediates the functional modulation of EPC biology in response to D-4F treatment and support the notion that the beneficial role of D-4F on EPCs may be one of the important components of its anti-atherogenic potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Van Lenten B, Wagner A, Anantharamaiah G, Navab M, Reddy S, Buga G, Fogelman A (2009) Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep 11:52–57

    Article  PubMed  Google Scholar 

  2. Getz GS, Wool GD, Reardon CA (2009) Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol 20:171–175

    Article  PubMed  CAS  Google Scholar 

  3. Sherman CB, Peterson SJ, Frishman WH (2010) Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 18:141–147

    Article  PubMed  Google Scholar 

  4. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D et al (2004) Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109:3215–3220

    Article  PubMed  CAS  Google Scholar 

  5. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG (2005) D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111:3126–3134

    Article  PubMed  CAS  Google Scholar 

  6. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87–102

    Article  PubMed  Google Scholar 

  7. Lamping K (2007) Endothelial progenitor cells: sowing the seeds for vascular repair. Circ Res 100:1243–1245

    Article  PubMed  CAS  Google Scholar 

  8. Steinmetz M, Nickenig G, Werner N (2010) Endothelial-regenerating cells: an expanding universe. Hypertension 55:593–599

    Article  PubMed  CAS  Google Scholar 

  9. Zhu J, Wang X, Chen J, Sun J, Zhang F (2006) Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res 37:484–489

    Article  PubMed  CAS  Google Scholar 

  10. Zhang L, Liu W, Chen Y, Song X, Jin Z, Lu S (2010) Proliferation, migration and apoptosis activities of endothelial progenitor cells in acute coronary syndrome. Chin Med J 123:2655–2661

    PubMed  Google Scholar 

  11. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. New Engl J Med 353:999–1007

    Article  PubMed  CAS  Google Scholar 

  12. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann W-K, Martin H et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690–1699

    Article  PubMed  Google Scholar 

  13. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG et al (2010) Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106:1904–1911

    Article  PubMed  CAS  Google Scholar 

  14. Hu C, Li Z, Du Z, Zhang A, Yang DY, Wu GF (2009) Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Chin Med J 122:548–555

    PubMed  CAS  Google Scholar 

  15. Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714

    Article  PubMed  Google Scholar 

  16. Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, De Geest B (2008) Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:278–283

    Article  PubMed  CAS  Google Scholar 

  17. Salvatore P, Casamassimi A, Sommese L, Fiorito C, Ciccodicola A, Rossiello R, Avallone B, Grimaldi V, Costa V, Rienzo M et al (2008) Detrimental effects of Bartonella henselae are counteracted by l-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci USA 105:9427–9432

    Article  PubMed  CAS  Google Scholar 

  18. Casamassimi A, Balestrieri ML, Fiorito C, Schiano C, Maione C, Rossiello R, Grimaldi V, Del Giudice V, Balestrieri C, Farzati B et al (2007) Comparison between total endothelial progenitor cell isolation versus enriched cd133+ culture. J Biochem 141:503–511

    Article  PubMed  CAS  Google Scholar 

  19. Miguel-Velado E, Pérez-Carretero FD, Colinas O, Cidad P, Heras M, López-López JR, Pérez-García MT (2010) Cell cycle-dependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells. Cardiovasc Res 86:383–391

    Article  PubMed  CAS  Google Scholar 

  20. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X et al (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39:133–144

    Article  PubMed  CAS  Google Scholar 

  21. Gong K, Li Z, Xu M, Du J, Lv Z, Zhang Y (2008) A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J Biol Chem 283:29028–29036

    Article  PubMed  CAS  Google Scholar 

  22. Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352–1364

    Article  PubMed  CAS  Google Scholar 

  23. Zhu J, Tao Q, Chen J, Wang X, Zhu J, Shang Y (2004) Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood. Acta Physiol Sin 56:357–364

    Google Scholar 

  24. Petoumenos V, Nickenig G, Werner N (2009) High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells. J Cell Mol Med 13:4623–4635

    Article  PubMed  CAS  Google Scholar 

  25. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA (2004) High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 101:6999–7004

    Article  PubMed  CAS  Google Scholar 

  26. D’Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D (2010) Structure/function relationships of apolipoprotein A-I mimetic peptides: implications for anti-atherogenic activities of high-density lipoprotein. Circ Res 107:217–227

    Article  PubMed  Google Scholar 

  27. Alev C, Ii M, Asahara T (2011) Endothelial progenitor cells: a “novel”tool for the therapy of ischemic diseases. Antioxid Redox Signal 15:949–965

    Google Scholar 

  28. White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM (2009) Vasculoprotective effects of apolipoprotein mimetic peptides: an evolving paradigm in HDL therapy. Vasc Dis Prev 6:122–130

    Article  PubMed  CAS  Google Scholar 

  29. Xu J, Zou M-H (2009) Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120:1266–1286

    Article  PubMed  Google Scholar 

  30. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 348:593–600

    Article  PubMed  Google Scholar 

  31. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D’Andrea D, De Micco F, Rivera NV et al (2010) Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 24:1981–1988

    Article  PubMed  CAS  Google Scholar 

  32. Liao Y, Chen L, Zeng T, Li Y, Fan Y, Hu L, Ling Y (2010) Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med 15:279–285

    Article  PubMed  Google Scholar 

  33. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, Damario D, Rebuzzi AG, Crea F (2009) From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Euro Heart J 30:890–899

    Article  Google Scholar 

  34. Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, Shuaib A (2007) High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 192:92–99

    Article  PubMed  CAS  Google Scholar 

  35. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, Stacchiotti A, Rezzani R, McClung JA, Aronow WS et al (2007) Long-term treatment with the apolipoprotein A-1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 322:514–520

    Article  PubMed  CAS  Google Scholar 

  36. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM (2002) Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105:290–292

    Article  PubMed  CAS  Google Scholar 

  37. Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS (2010) 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J 25:290–300

    Article  PubMed  Google Scholar 

  38. Jiang H, Chen SS, Yang J, Chen J, He B, Zhu LH, Wang L (2011) CREB-binding protein silencing inhibits thrombin-induced endothelial progenitor cells angiogenesis. Mol Biol Rep. doi:10.1007/s11033-011-1035-4

  39. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809

    Article  PubMed  CAS  Google Scholar 

  40. Feng Y, Gordts SC, Chen F, Hu Y, Van Craeyveld E, Jacobs F, Carlier V, Feng Y, Zhang Z, Xu Q et al (2011) Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice. Atherosclerosis 214:271–278

    Article  PubMed  CAS  Google Scholar 

  41. Feng Y, Van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B (2009) Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 113:755–764

    Article  PubMed  CAS  Google Scholar 

  42. Hamed S, Brenner B, Roguin A (2011) Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovasc Res 91:9–15

    Article  PubMed  CAS  Google Scholar 

  43. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, Han ZC (2006) Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 47:1227–1237

    Article  PubMed  CAS  Google Scholar 

  44. Yu X, Song M, Chen J, Zhu G, Zhao G, Wang H, Hunag L (2010) Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. Mol Biol Rep 37:2423–2429

    Article  PubMed  CAS  Google Scholar 

  45. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL et al (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98:63–72

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We appreciate Dr. Baran Aksut for the revision of the manuscript. This work was supported by the Basic Research Project (Natural Science Foundation) of Jiangsu Province (BK2008220, BK2010324) and the National Natural Science Foundation of China (81070096).

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaizheng Gong.

Additional information

Zhengang Zhang and Jianhua Qun authors contributed equally to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 35 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., Qun, J., Cao, C. et al. Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway. Mol Biol Rep 39, 4445–4454 (2012). https://doi.org/10.1007/s11033-011-1233-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-1233-0

Keywords

Navigation